[Dental treatment and anti-thrombotic therapy. Part II: the era of new anti-thrombotic drugs].

Refu'at ha-peh veha-shinayim (1993) Pub Date : 2014-01-01
T Chackartchi, S Sachar Helft, M Findler
{"title":"[Dental treatment and anti-thrombotic therapy. Part II: the era of new anti-thrombotic drugs].","authors":"T Chackartchi,&nbsp;S Sachar Helft,&nbsp;M Findler","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Surgical intra-oral treatment for patients under antithrombotic therapy presents a challenge for the dental team. Within the last few years evidence based systematic reviews established new clinical guidelines for wide groups of patients which need to use antithrombotic treatment. The expected increase in use of antithrombotic treatment forced the pharmaceutical industry to provide new treatments. The former anticoagulant and anti-platelets aggregation groups of drugs were limited to small variety of medication. The search for the new treatments with ideal properties led to newly invented groups of drugs. In this article we will describe the new advancements in anti-thrombotic treatments. The article will summarize the limited knowledge of surgical management of patients under the new anti-thrombotic medications and the recommended approach for oral surgical procedures.</p>","PeriodicalId":82453,"journal":{"name":"Refu'at ha-peh veha-shinayim (1993)","volume":"31 1","pages":"43-9, 63"},"PeriodicalIF":0.0000,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Refu'at ha-peh veha-shinayim (1993)","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Surgical intra-oral treatment for patients under antithrombotic therapy presents a challenge for the dental team. Within the last few years evidence based systematic reviews established new clinical guidelines for wide groups of patients which need to use antithrombotic treatment. The expected increase in use of antithrombotic treatment forced the pharmaceutical industry to provide new treatments. The former anticoagulant and anti-platelets aggregation groups of drugs were limited to small variety of medication. The search for the new treatments with ideal properties led to newly invented groups of drugs. In this article we will describe the new advancements in anti-thrombotic treatments. The article will summarize the limited knowledge of surgical management of patients under the new anti-thrombotic medications and the recommended approach for oral surgical procedures.

牙科治疗和抗血栓治疗。第二部分:新型抗血栓药物的时代]。
手术口腔内治疗的病人在抗血栓治疗提出了一个挑战,牙科团队。在过去几年中,基于证据的系统评价为需要使用抗血栓治疗的广大患者群体建立了新的临床指南。抗血栓治疗使用的预期增加迫使制药行业提供新的治疗方法。以前抗凝和抗血小板聚集药物组仅限于小品种药物。寻找具有理想特性的新疗法导致了新发明的药物组。在这篇文章中,我们将描述抗血栓治疗的新进展。本文将总结有限的知识,手术管理的病人在新的抗血栓药物和推荐的方法进行口腔外科手术。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书